An italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
-
Personalized medicine
At the present, one of the major problems in cancer treatment lies in the lack of suitable assays to select patients more likely to respond to a given anticancer therapy
Updated | 26/11/2009 11:11
News
-
MediaPharma has established the Scientific Advisory Board
Updated | 27/04/2010 16:04 -
MediaPharma on Tg Leonardo
RAI TG Leonardo interviews Prof. S. Iacobelli, Founder and President of MediaPharma
Updated | 15/03/2010 15:03 -
MediaPharma wins the semi-final of the European Venture Contest in Turin!
Updated | 24/11/2009 14:02
Subscribe to Rss Feed
ShareMediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
